Neuroimmunologic Disease: Experimental and Clinical Aspects
- 6 July 1979
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 14 (7) , 49-58
- https://doi.org/10.1080/21548331.1979.11707578
Abstract
Recent studies in an animal model of autoimmune disease, experimental allergic encephalomyelitis, have provided clues about possible mechanisms governing the production and control of human demyelinating disease, particularly multiple sclerosis. The findings are reviewed, and their relevance to concepts about the events involved in the induction and loss of immunologic tolerance is emphasized.Keywords
This publication has 7 references indexed in Scilit:
- Neuroimmunologic Diseases of Animals and Humans. The Joseph E. Smadel Memorial LectureClinical Infectious Diseases, 1979
- Relative affinity of antisera for myelin basic protein (MBP) and degree of affinity heterogeneityMolecular Immunology, 1979
- EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: SEQUESTERED ENCEPHALITOGENIC DETERMINANT IN THE BOVINE MYELIN BASIC PROTEIN12Journal of Neurochemistry, 1979
- Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats.The Journal of Experimental Medicine, 1978
- Myelin basic protein serum factor (MBP-SF) in adult lewis rats: A method for detection and evidence that MBP-SF influences the appearance of antibody to MBP in animals developing experimental allergic encephalomyelitisImmunochemistry, 1978
- MBP-SF, a prominent serum factor in suckling lewis rats that additively inhibits the primary binding of Myelin Basic Protein (MBP) to syngeneic anti-MBP antibodiesImmunochemistry, 1978
- Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosisNeurology, 1977